A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

Por Heider, Karl-Heinz, Kiefer, Kerstin, Zenz, Thorsten, Volden, Matthias, Stilgenbauer, Stephan, Ostermann, Elinborg, Baum, Anke, Lamche, Herbert, Küpcü, Zaruhi, Jacobi, Alexander, Müller, Steffen, Hirt, Ulrich, Adolf, Günther R., Borges, Eric
Publicado em 2011